Bleomycin for older patients: Less is more Journal Article
| Author: | Moskowitz, A. J. |
| Article Title: | Bleomycin for older patients: Less is more |
| Abstract: | In this issue of Blood, Böll et al report on the toxicity of 2 vs 4 cycles of bleomycin-containing chemotherapy in older, early stage, favorable patients with Hodgkin lymphoma (HL) and show that 2 cycles, but no more, of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) is well tolerated in this patient population. © 2016 by The American Society of Hematology. |
| Journal Title: | Blood |
| Volume: | 127 |
| Issue: | 18 |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2016-05-05 |
| Start Page: | 2167 |
| End Page: | 2168 |
| Language: | English |
| DOI: | 10.1182/blood-2016-03-699090 |
| PROVIDER: | scopus |
| PUBMED: | 27151735 |
| DOI/URL: | |
| Notes: | Review -- Export Date: 2 June 2016 -- Source: Scopus |
